Table 1.
Clinical characteristics at baseline examination for all study participants (n=513) and participants with <80% available FI-Lab21 parameters (n=13)
| Clinical characteristics | All participants (n=513) | Participants with <80% FI-Lab21 parameters (n=13) |
|---|---|---|
| Female % (n) | 67.4 (346) | 84.6 (11) |
| Age (years) | 82.8±6.2 | 83.2±5.4 |
| Height (cm) | 163±9.3 | 160.8±5.9 |
| Weight (kg) | 72.2±16.2 | 71.2±15.4 |
| BMI (kg/m2) | 27.1±5.5 | 27.4±5.0 |
| Unintentional weight loss >4.5 kg in last year % (n) | 37 (190) | 84.6 (11) |
| MMSE (points) | 25.5±4.3 | 25.75±3.5 |
| GDS (points) | 4.1±2.7 | 4.2±1.9 |
| Timed “up and go” test >19 seconds or unable to perform % (n) | 65.7 (332) | 76.9 (10) |
| Barthel Index | 68.6±20.9 | 63.5±23.9 |
| Heart failure % (n) | 56.9 (292) | 53.8 (7) |
| Peripheral vascular disease % (n) | 14.8 (76) | 0 (0) |
| Coronary infarction % (n) | 12.5 (64) | 7.7 (1) |
| Stroke % (n) | 20.9 (107) | 15.4 (2) |
| Cancer % (n) | 15.8 (81) | 7.7 (1) |
| Diabetes mellitus % (n) | 37 (190) | 61.5 (8) |
| Chronic lung disease % (n) | 20.5 (105) | 15.4 (2) |
| Kidney disease % (n) | 56.7 (291) | 61.5 (8) |
| Urinary incontinence or catheterized % (n) | 38.8 (199) | 61.5 (8) |
| Constipation % (n) | 22.8 (117) | 0 (0) |
| >5 medications % (n) | 96.3 (494) | 92.3 (12) |
Note: Data are presented as mean ± SD (unless otherwise stated).
Abbreviations: BMI, body mass index; FI-Lab21, 21-item frailty index based on laboratory blood and urine tests; GDS, Geriatric Depression Scale; MMSE, Mini-Mental State Examination.